191 related articles for article (PubMed ID: 8623232)
1. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232
[No Abstract] [Full Text] [Related]
2. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
Sugito K; Morozumi K; Oikawa T
Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
[No Abstract] [Full Text] [Related]
3. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
[No Abstract] [Full Text] [Related]
4. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
Sharma A; Jain S; Gupta R; Guleria S; Agarwal S; Dinda A
Indian J Pathol Microbiol; 2010; 53(4):651-7. PubMed ID: 21045386
[TBL] [Abstract][Full Text] [Related]
5. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
[TBL] [Abstract][Full Text] [Related]
8. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers.
Marchewka Z; Kuźniar J; Zynek-Litwin M; Falkiewicz K; Szymańska B; Roszkowska A; Klinger M
Transplant Proc; 2009 Jun; 41(5):1660-5. PubMed ID: 19545703
[TBL] [Abstract][Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
[TBL] [Abstract][Full Text] [Related]
10. Effect of subclinical rejection on renal allograft histology and function at 6 months.
Rush D; Jeffery J; Trpkov K; Solez K; Gough J
Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
[No Abstract] [Full Text] [Related]
11. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
[No Abstract] [Full Text] [Related]
12. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
Morozumi K; Thiel G; Gudat F; Mihatsch MJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
[No Abstract] [Full Text] [Related]
13. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
Morales JM; Andres A; Rengel M; Rodicio JL
Nephrol Dial Transplant; 2001; 16 Suppl 1():121-4. PubMed ID: 11369839
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic findings in routine biopsies of renal transplant allografts.
Toki K; Kyo M; Takahara S; Hatori M; Morozumi K; Ichimaru N; Wang JD; Ding XQ; Miyamoto M; Oka K; Kyakuno M; Kojima Y; Kokado Y; Okuyama A
Transplant Proc; 1999 Sep; 31(6):2655-8. PubMed ID: 10500759
[No Abstract] [Full Text] [Related]
15. The role of tacrolimus in adult kidney transplantation: a review.
Laskow DA; Neylan JF; Shapiro RS; Pirsch JD; Vergne-Marini PJ; Tomlanovich SJ
Clin Transplant; 1998 Dec; 12(6):489-503. PubMed ID: 9850440
[TBL] [Abstract][Full Text] [Related]
16. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
Asante-Korang A; Boyle GJ; Webber SA; Miller SA; Fricker FJ
J Heart Lung Transplant; 1996 Apr; 15(4):415-22. PubMed ID: 8732602
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus may be associated with lower osteonecrosis rates after renal transplantation.
Sakai T; Sugano N; Kokado Y; Takahara S; Ohzono K; Yoshikawa H
Clin Orthop Relat Res; 2003 Oct; (415):163-70. PubMed ID: 14612643
[TBL] [Abstract][Full Text] [Related]
18. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
Jain A
Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
[No Abstract] [Full Text] [Related]
19. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA?
Takeda A; Morozumi K; Uchida K; Yokoyama I; Takagi H; Yoshida A; Fujinami T; Thiel G; Gudat F; Mihatsch MJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):515-7. PubMed ID: 8438396
[No Abstract] [Full Text] [Related]
20. Is a late graft biopsy at 3 years after transplantation effective for improving the long-term outcome of renal allografts using cyclosporine?
Morozumi K; Takeda A; Uchida K; Oda A; Oikawa T; Sugito K; Kodera K; Fujinami T; Tominaga Y; Yoshida A
Transplant Proc; 1994 Apr; 26(2):945-8. PubMed ID: 8171713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
